Download Files:
Products Details
Product Description
– SARS-CoV-2 3CLpro-IN-1 (Compound 14c) is a potent inhibitor of SARS-CoV-2 3CLpro. 3CLpro (main coronaviruses cysteine-protease) has been identified as a promising target for the development of antiviral agents. SARS-CoV-2 3CLpro-IN-1 has the potential for the research of infection diseases[1].
Web ID
– HY-144833
Shipping
– Room temperature
Applications
– COVID-19-anti-virus
Molecular Formula
– C27H30ClN3O3S
References
– [1]Stille JK, et al. Design, synthesis and in vitro evaluation of novel SARS-CoV-2 3CLpro covalent inhibitors. Eur J Med Chem. 2022 Feb 5;229:114046.
CAS Number
– 2757970-20-8
Molecular Weight
– 512.06
SMILES
– O=C(NCCC1=CC=CC(Cl)=C1)C(N(C2=CC=C(C(C)(C)C)C=C2)S(=O)(C=C)=O)C3=CC=CN=C3
Clinical Information
– No Development Reported
Research Area
– Infection
Solubility
– 10 mM in DMSO
Target
– SARS-CoV
Pathway
– Anti-infection
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
